64XBIO Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
15
64XBIO General Information
Description
Developer of a mammalian cell line discovery platform designed to enhance the design of cell lines for biomanufacturing and therapeutics. The company's platform helps to bring cell and gene therapies to patients effectively and provides purpose-built genetically engineered cell lines for the efficiency of viral vector production, enabling pharmaceutical and biotechnology companies to improve manufacturing capacity and reduce manufacturing costs.
Contact Information
Website
www.64xbio.comCorporate Office
- 1000 Marina Boulevard
- Suite 100
- Brisbane, CA 94005
- United States
Corporate Office
- 1000 Marina Boulevard
- Suite 100
- Brisbane, CA 94005
- United States
64XBIO Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 29-Apr-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 19-Jan-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 18-Apr-2019 | $4.38M | $4.5M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 22-Aug-2018 | $120K | $120K | Completed | Generating Revenue |
64XBIO Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-2 | ||||||||
| Series A-5 | ||||||||
| Series A-4 | 245,857 | $0.000100 | $7.24 | $7.24 | 1x | $7.24 | 6.19% | |
| Series A-3 | 331,493 | $0.000100 | $4.83 | $4.83 | 1x | $4.83 | 8.35% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
64XBIO Comparisons
Industry
Financing
Details
64XBIO Competitors (3)
One of 64XBIO’s 3 competitors is Hexagon Bio, a Venture Capital-Backed company based in Menlo Park, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hexagon Bio | Venture Capital-Backed | Menlo Park, CA | ||||
| Conagen | Corporate Backed or Acquired | Bedford, MA | ||||
| Codexis | Formerly VC-backed | Redwood City, CA |
64XBIO Patents
64XBIO Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024373384-A1 | Production technologies | Pending | 01-Nov-2023 | ||
| EP-4802088-A1 | Production technologies | Pending | 01-Nov-2023 | ||
| WO-2025096931-A1 | Production technologies | Inactive | 01-Nov-2023 | ||
| AU-2023228817-A1 | Insect cells and methods for engineering the same | Pending | 01-Mar-2022 | ||
| EP-4486902-A1 | Insect cells and methods for engineering the same | Pending | 01-Mar-2022 | C12N15/86 |
64XBIO Signals
64XBIO Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Charles River Incubator Program | Accelerator/Incubator | |||
| G Ventures (VC) | Venture Capital | Minority | ||
| Neman Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| BoxGroup | Venture Capital | Minority |
64XBIO FAQs
-
When was 64XBIO founded?
64XBIO was founded in 2017.
-
Where is 64XBIO headquartered?
64XBIO is headquartered in Brisbane, CA.
-
What is the size of 64XBIO?
64XBIO has 22 total employees.
-
What industry is 64XBIO in?
64XBIO’s primary industry is Drug Discovery.
-
Is 64XBIO a private or public company?
64XBIO is a Private company.
-
What is 64XBIO’s current revenue?
The current revenue for 64XBIO is .
-
How much funding has 64XBIO raised over time?
64XBIO has raised $59.5M.
-
Who are 64XBIO’s investors?
Charles River Incubator Program, G Ventures (VC), Neman Ventures, , and BoxGroup are 5 of 15 investors who have invested in 64XBIO.
-
Who are 64XBIO’s competitors?
Hexagon Bio, Conagen, and Codexis are competitors of 64XBIO.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process